Study Results from Public Assistance - Paris Hospitals (AP-HP) Update Understanding of Hypophosphatemia (Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody To Fgf23, In Children With X-linked Hypophosphatemia)

Source :: Immunotherapy Weekly. March 30, 2022, 630
Publication Year :: 2022
Abstract: 2022 MAR 30 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Current study results on Nutritional and Metabolic Diseases and Conditions - Hypophosphatemia have been published. [...]

Subjects :: Welfare -- Research
Alfacalcidol -- Research
Calcifediol -- Research
Vitamin D -- Research
Immunotherapy -- Research
Phosphates -- Research
Hypophosphatemia -- Research -- Care and treatment
Health

Tools